Oral Terbinafine-Induced Bullous Pemphigoid

Annals of Pharmacotherapy

Volumn 37, Issue 11, 2003, Pages 1625-1627

  Aksakal, Burhan A ^a,b   Özsoy, Esra ^a   Arnavut, Önder ^a   Gürer, Mehmet Ali ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Bullous pemphigoid; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; PREDNISONE; STEROID; TERBINAFINE;

AGED; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; ERYTHEMA MULTIFORME; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; HUMAN; MALE; NEUROTOXICITY; ONYCHOMYCOSIS; PEMPHIGOID; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN BIOPSY; SKIN DISEASE; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; TASTE DISORDER; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

AGED; ANTIFUNGAL AGENTS; HUMANS; MALE; NAPHTHALENES; ONYCHOMYCOSIS; PEMPHIGOID, BULLOUS;

EID: 0142151438     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D013     Document Type: Article

References (24)

1. Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991;30:307-12.
2. Bastuji-Garin S, Joly P, Picard Dahan C, Bernard P, Vaillant L, Pauwels C, et al. Drugs associated with bullous pemphigoid. Arch Dermatol 1996;132:272-6.
3. Brenner S, Ruocco V, Bialy-Golan A, Tur E, Flaminio C, Ruocco E, et al. Pemphigus and pemphigoid-like effects of nifedipine on in vitro cultured normal human skin explants. Int J Dermatol 1999;38:36-40.
4. Kimyai-Asadi A, Usman A, Nousari HC. Ciprofloxacin-induced bullous pemphigoid (letter). J Am Acad Dermatol 2000;42(5 pt 1):847.
5. Millard TP, Smith HR, Black MM, Barker WN. Bullous pemphigoid during systemic therapy with chloroquine. Clin Exp Dermatol 1999;24:263-5.
6. Shapiro M, Li LJ, Miller J. Terbinafine-induced neutropenia. Br J Dermatol 1990;140:1196-7.
7. Gupta AK, Sibbald RG, Knowles SR, Lynde CW, Shear NH. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug induced psoriasis. J Am Acad Dermatol 1997;36:858-62.
8. Hall M, Monka C, Krupp P, O'Sullivan D. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol 1997;133:1213-9.
9. Gupta AK, Shear NH. Terbinafine: an update. J Am Acad Dermatol 1997;37:979-88.
10. Finlay AY. Global overview of Lamisil. Br J Dermatol 1994;130:1-3.
11. Bennet ML, Jorrizo JL, White WL. Generalized pustular eruptions associated with oral terbinafine. Int J Dermatol 1999;38:596-600.
12. Rzany B, Mockenhaupt M, Gehring W, Schopf E. Stevens-Johnson syndrome after terbinafine therapy (letter). J Am Acad Dermatol 1994;30:509.
13. White SI, Bowen-Jones D. Toxic epidermal necrolysis induced by terbinafine in a patient on long term antiepileptics. Br J Dermatol 1996; 134:188-9.
14. Todd P, Halpern S, Munro DD. Oral terbinafine and erythema multiforme. Clin Exp Dermatol 1995;20:247-8.
15. Goeteyn V, Naeyaert JM, Lambert J, Monbaliu L, Vermander F. Is systemic autoimmune disease a risk factor for terbinafine induced erythema multiforme? Br J Dermatol 2000;142:578-9.
16. McCellan JK, Wiseman LR, Markham A. Terbinafine. An update of its use in superficial mycoses. Drugs 1999;58:179-202.
17. Dupin N, Gorin I, Djien V, Helal H, Zylberg L, Leibowitch M, et al. Acute generalized exanthematous pustulosis induced by terbinafine. Arch Dermatol 1996;132:1253-4.
18. Kempinaire A, De Raeve L, Merckz M, De Coninck A, Bauwens M, Roseeuw D. Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch test result. J Am Acad Dermatol 1997;37:653-5.
19. Gupta AK, Lynde CW, Lauzon GJ, Mehlmauer MA, Braddock SW, Miller CA, et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 1998;138:529-32.
20. Wach F, Stolz W, Hein R, Landthaler M. Severe erythema annulare centrifugum-like psoriatic drug eruption induced by terbinafine. Arch Dermatol 1995;131:960-1.
21. Brooke R, Coulson IH, Al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998;139:1132-3.
22. Murphy M, Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol 1988;138:708-9.
23. Bonsmann G, Schiller M, Luger TA, Stander S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001;44:925-31.
24. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.